News from Bayer HealthCare, Diabetes Care A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2013, 05:16 ET Bayer Receives Approval for Xofigo® (radium Ra 223 dichloride) Injection in Europe

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo® (radium Ra 223...


Oct 29, 2013, 09:12 ET 500,000 People Call for Urgent Action to Prevent Atrial Fibrillation-Related Strokes

-Not intended for U.K. media- Atrial fibrillation is an under-diagnosed, undertreated abnormal heart rhythm that increases stroke risk five-fold...


Oct 28, 2013, 20:01 ET 500,000 People Call for Urgent Action to Prevent Atrial Fibrillation-Related Strokes

Atrial fibrillation is an under-diagnosed, undertreated abnormal heart rhythm that increases stroke risk five-fold compared to the general...


Oct 21, 2013, 10:00 ET Bayer's CONTOUR® NEXT LINK Cleared For Use With Medtronic's New MiniMed® 530G With Enlite®

Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR® NEXT LINK blood glucose monitoring...


Oct 16, 2013, 12:39 ET Bayer HealthCare Celebrates Opening of State-of-the Art U.S. Headquarters in Whippany

 Bayer HealthCare today announced the opening of its new U.S. headquarters on a 94-acre campus in Whippany, New Jersey, within...


Oct 09, 2013, 08:00 ET MULTIMEDIA ASSETS NOW AVAILABLE: FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...


Oct 03, 2013, 08:32 ET Bayer Introduces Kogenate® FS Antihemophilic Factor (Recombinant) with Vial Adapter at 2013 NHF Meeting

 Bayer HealthCare announced today that the company is introducing Kogenate® FS antihemophilic factor (recombinant) with Vial Adapter. Vial...


Oct 01, 2013, 09:00 ET Bayer HealthCare Wants You To Vote For Your Favorite "Chatty Cat"!

 The official voting period for Bayer HealthCare Animal Health's Advantage® II for cats Chatty Cat Challenge opens today....


Sep 20, 2013, 09:20 ET Zusammengefasste Ergebnisse der EINSTEIN-Phase-III-Studien bestätigen Xarelto® von Bayer als effektives Monotherapeutikum bei venösen Thromboembolien

Behandlung und Prävention venöser Blutgerinnsel: - Alle 37 Sekunden stirbt ein Mensch in der westlichen Welt an Blutgerinnseln, die in...


Sep 17, 2013, 08:30 ET Bayer to Present Data on Multiple Oncology Compounds at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013

 Bayer HealthCare announced  today that data from the company's oncology portfolio, including Nexavar® (sorafenib)...


Sep 10, 2013, 08:01 ET Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy

 Bayer HealthCare has entered into a strategic alliance with the Broad Institute in Cambridge, Massachusetts in the area of oncogenomics and...


Sep 06, 2013, 09:30 ET Bayer HealthCare Launches "Chatty Cat Challenge" to Find Out What Keeps Cats Healthy and Happy

 Bayer HealthCare Animal Health's Advantage® II for cats today launches the Chatty Cat Challenge, an opportunity for cat owners...


Aug 30, 2013, 02:30 ET Bayer's Stivarga® (regorafenib) Tablets Approved in Europe

 Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved...


Jul 09, 2013, 09:42 ET Bayer Announces 2013 Recipients of Bayer Hemophilia Awards Program

 Bayer HealthCare has announced the 2013 recipients of the Bayer Hemophilia Awards Program (BHAP). This year, the company awarded more than $2...


May 16, 2013, 09:09 ET Strategic move to strengthen Consumer Care business: Bayer to acquire Steigerwald Arzneimittelwerk GmbH

Bayer signed an agreement Thursday to acquire 100% of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held...


May 10, 2013, 13:01 ET Bayer Employee Named Rising Star by Healthcare Businesswomen's Association

Bayer HealthCare is pleased to announce that Carla Oliveira  has  been named a Rising Star by The Healthcare Businesswomen's...


May 07, 2013, 17:30 ET Don't Leave Home Without It: Vanessa Williams, Bayer HealthCare and WomenHeart Launch Handbags & Hearts to Urge Women to Make Over Their Handbags to Include Aspirin and Be Better Prepared for a Heart Attack

Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and...


May 07, 2013, 17:22 ET Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc.

 Bayer's planned acquisition of Conceptus, Inc., based in Mountain View, California (NASDAQ: CPTS) is entering its next phase: Evelyn...


May 01, 2013, 13:43 ET Putting Meals on the Table for People in Need: Sheryl Crow and One A Day® Women's Brand on a Nutrition Mission to Help Feed the More Than 50 Million Americans Facing Food Insecurity

 Today, Bayer HealthCare LLC, the makers of One A Day® Women's Multivitamins, along with Feeding America®, the nation's leading...


Apr 08, 2013, 02:30 ET Bayer's Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

 Bayer HealthCare announced today that the New Drug Application (NDA) for its oral investigational compound riociguat has been accepted for...